Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.19
+0.12 (1.32%)
Feb 21, 2025, 4:00 PM EST - Market closed
Amicus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -56.11 | -151.58 | -236.57 | -250.46 | -276.85 | Upgrade
|
| Depreciation & Amortization | 8.55 | 7.87 | 5.34 | 6.21 | 8.85 | Upgrade
|
| Other Amortization | 2.26 | 2.62 | 2.63 | 2.49 | 1.79 | Upgrade
|
| Asset Writedown & Restructuring Costs | 9.21 | 2.73 | 18.18 | - | 0.1 | Upgrade
|
| Stock-Based Compensation | 84.91 | 86.08 | 76.51 | 57.84 | 49.15 | Upgrade
|
| Other Operating Activities | 16.23 | 31.19 | 7.21 | 10.37 | 15.74 | Upgrade
|
| Change in Accounts Receivable | -19.48 | -20.11 | -17.33 | -8.19 | -11.22 | Upgrade
|
| Change in Inventory | -73.65 | -44.61 | -5.34 | -7.79 | -4.64 | Upgrade
|
| Change in Accounts Payable | -16.52 | 49.2 | -6.38 | 7.43 | -10.61 | Upgrade
|
| Change in Other Net Operating Assets | 10.71 | -32.46 | -10.83 | -20.39 | -5.6 | Upgrade
|
| Operating Cash Flow | -33.89 | -69.09 | -166.58 | -202.49 | -233.29 | Upgrade
|
| Capital Expenditures | -3.55 | -7.44 | -3.77 | -3.88 | -3.23 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 3.41 | - | - | Upgrade
|
| Investment in Securities | 2.99 | 105.5 | 92.67 | 82.65 | -10.35 | Upgrade
|
| Investing Cash Flow | -0.56 | 98.06 | 92.32 | 78.76 | -13.58 | Upgrade
|
| Long-Term Debt Issued | - | 387.36 | - | - | 385.93 | Upgrade
|
| Long-Term Debt Repaid | -0.1 | -408.32 | -0.28 | -0.48 | -155.33 | Upgrade
|
| Net Debt Issued (Repaid) | -0.1 | -20.96 | -0.28 | -0.48 | 230.6 | Upgrade
|
| Issuance of Common Stock | 27.24 | 103.21 | 4.31 | 229.21 | 42.28 | Upgrade
|
| Repurchase of Common Stock | -22.03 | -17.92 | -11.49 | -15.01 | -10.03 | Upgrade
|
| Other Financing Activities | - | -2.65 | - | -1.65 | - | Upgrade
|
| Financing Cash Flow | 5.12 | 61.68 | -7.46 | 212.07 | 262.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | -4.03 | 6.31 | -14.62 | -5.05 | 3.83 | Upgrade
|
| Net Cash Flow | -33.36 | 96.96 | -96.34 | 83.29 | 19.82 | Upgrade
|
| Free Cash Flow | -37.44 | -76.53 | -170.34 | -206.38 | -236.52 | Upgrade
|
| Free Cash Flow Margin | -7.09% | -19.16% | -51.74% | -67.55% | -90.66% | Upgrade
|
| Free Cash Flow Per Share | -0.12 | -0.26 | -0.59 | -0.76 | -0.91 | Upgrade
|
| Cash Interest Paid | 58.96 | 36.09 | 34.36 | 30.47 | 24.68 | Upgrade
|
| Cash Income Tax Paid | 8.21 | 8.53 | 1.61 | 20.03 | 10.37 | Upgrade
|
| Levered Free Cash Flow | 5.41 | -25.89 | -94.23 | -84.97 | -137.55 | Upgrade
|
| Unlevered Free Cash Flow | 34.14 | 2.84 | -73.66 | -67.16 | -125.32 | Upgrade
|
| Change in Net Working Capital | 77.05 | 37.74 | 23.98 | 2.38 | 27.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.